8 TECH OUTLOOKMay 2016Traditionally, financial services and pharmaceutical organizations are not early adopters of the cloud. Just over 5 years ago, one would see frowns and dismissive eyes, when cloud vendors would present their value proposition. The world has since, moved on. Some interesting attempts about cloud-adoption suggest that we are willing to decide in favor of the cloud, and some pharmaceutical companies are not holding back. Emails on the cloud (aka Office 365) are common in Pharma, not withstanding the perceived risk that critical information about products, strategy and litigation is sprinkled all over business email messages. Commercial systems that contain customer contract information, pricing, rebates and chargebacks are being hosted on external data centers, and often on the cloud. So, clearly, technology leaders have assessed that the risks to sensitive business information are not increased by moving them to the cloud. In fact, several companies may have found their in-house data centers rank lower on infrastructure quality, security, vulnerability and disaster recovery. Of course, parameters like up-time, performance and latency are not The "Cloud First" Approach to Life SciencesBy Sunil Anand, CIO, Jubilant Life Sciences Ltd Sunil AnandIn My Opinion
< Page 7 | Page 9 >